STK11/LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition (Sitthideatphaiboon et al., 2021). The gene discussed is KEAP1; the disease is non-small cell lung carcinoma.